Foundation for innovation
in Cardiometabolism and Nutrition

Targeted delivery of LXR-agonists to atherosclerotic lesions mediated by polydiacetylene micelles

Nanoscale

Targeted delivery of LXR-agonists to atherosclerotic lesions mediated by polydiacetylene micelles

Restez en contact

Recevez toute l’actualité de la fondation ICAN

This field is for validation purposes and should be left unchanged.

Nos fondateurs

CERTIFIÉ ISO 9001

Nos soutiens institutionnels

Notre réseau